Fuertes, Melody A.
HRN: 22-59-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
CEFTAZIDIME 1GM (VIAL)
01/17/2025
01/24/2025
IVTT
2 Gm
Q 8h
DM Foot With Gangrene
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes